Contact Us  |  Site Map  |  Search  |  Client Login  
 
 
Boston Millennia Partners
   
  Boston Millennia Partners provides private equity financing to high growth companies in the healthcare and life sciences industry. Our team brings over one hundred years of combined private equity experience to the investment process. Our broad experience, combined with expertise in finance; operations; engineering; life sciences research and development; partnering with pharmaceutical companies; business development; executive recruiting; and law provides significant value to the companies in which we invest. Since the early 1980’s, members of our team have managed seven venture capital partnerships with very successful results for our investors and our entrepreneurs. The growth and success of our portfolio companies have, in turn, allowed us to grow and expand our capital base to over $700 million under management.  
 

Boston Millennia Partners is pleased to announce that its portfolio company, Odyssey Logistics & Technology Corporation, a leading global logistics provider, has achieved revenue growth in excess of 66% in 2011. Benefiting from solid organic growth as well as successfully integrating four recent acquisitions from April 2010 through January 2011, the Company is continuing its acquisition program in 2012. "Odyssey is benefiting from scale, as its larger transportation network enables it to lower costs to its customers. Also,” says Martin Hernon, a partner at Boston Millennia Partners and member of the Odyssey Board of Directors, “the company is an attractive acquisition partner for business owners, as Odyssey management strives to maintain a very fair and congenial culture for the companies that it acquires." Click Here to Read More


 
   
   

PAREXEL Announces Agreement to Acquire Quantum Solutions India
PAREXEL International Corporation announced today that the Company has signed a definitive agreement to acquire all of the business assets of privately-owned Quantum Solutions India (“QSI”), a leading provider of specialized pharmacovigilance services, based in Chandigarh, India.

Learn More >

Millennia Portfolio Company, MedAptus, Chosen by Maury Regional Medical Center to Improve Inpatient Coding, Billing Processes
MedAptus® announces that Maury Regional Medical Center has contracted for the company’s Professional Charge Capture (Pro) solution for deployment to Family Health Group, the physician business unit within the Maury hospital system.

Learn More >

Boston Millennia Portfolio Company, Collegium Pharmaceutical Raises $50 million Financing
Collegium Pharmaceutical, Inc., announces it has raised a $50 million financing. Collegium plans to use the proceeds to advance its lead abuse-deterrent product, Xtampza ER through potential FDA approval and commercial launch and to fund operational growth and other pipeline development programs.

Learn More >

Liquidity Events Take Center Stage for Boston Millennia Partners Funds
2014 was a year of favorable exit events for several companies in the Boston Millennia Partners portfolio. We look back on the year and highlight the portfolio companies, CardioMEMS, Inc. Precision Dermatology, Inc. and PHT which produced over $130 million in cash returns for our partnerships.

Learn More >

Boston Millennia Partners Portfolio Company, PHT Corporation, is Acquired by ERT
PHT Corporation (PHT), the eClinical innovator leading the adoption of patient-driven mobile apps for improved clinical research, announced today that they have signed a definitive agreement under which ERT will acquire PHT.

Learn More >

Boston Millennia Partners Portfolio Company, Odyseey Logistics & Technology's Growth Featured on newstimes.com
Odyssey Logistics & Technology Corp., the Danbury shipping company growing at breakneck speed, is featured on newstimes.com

Learn More >

Boston Millennia Portfolio Company, Odyssey Logistics & Technology Corp., Announces Earnings Growth of 60%+
Odyssey Logistics & Technology Corp. announces that earnings grew more than 60% in 2014, continuing a trend of consecutive years of double digit year-over-year revenue and earnings growth. The increase was fueled by strong organic performance, as well as continued acquisition strategy execution.

Learn More >

Boston Millennia Partners, Portfolio Company, MedAptus®, Partners with athenahealth
MedAptus® announces that it has partnered with athenahealth through athenahealth’s More Disruption Please (MDP) program. Together the companies will work to link athenahealth’s growing network of more than 59,000 health care providers.

Learn More >

Boston Millennia Portfolio Company, Histogenics, Completes Successful IPO
Millennia Portfolio Company, Histogenics, a regenerative medicine company, today announced the pricing of its underwritten initial public offering of 5,909,091 shares of its common stock at a price to the public of $11.00 per share.

Learn More >

Boston Millennia Partners Portfolio Company, CardioMEMS HF System Tests Positive
St. Jude Medical’s evaluation of the CardioMEMS Heart Failure (HF) System shows a significant reduction in 30-day hospital readmission rates for patients aged 65 and above. The System is a first-of-its-kind monitoring device that tracks the level of pressure borne by heart-failure patients.


Learn More >

 
 
Click Here to receive news updates
from Boston Millennia Partners >



 
CEO Video Dana Callow on Bloomberg TV with Pimm Fox

Video: Click Here to View
CEO Video NECN CEO Corner Interview With Dana Callow

Video: Large | Small
CEO Video Dana Callow on PBS’s Greater Boston With Emily Rooney

Video: Large | Small
spacer
   
Healthcare information is becoming broadly available to consumers, which is expanding basic demand.
Learn More >
 
   
Three key areas of opportunity in the Life Sciences sector are drug discovery & development...
Learn More >
 
 
  | Our Firm      Our Team      Our Portfolio      Resources      News  
  © 2015 Boston Millennia Partners  All Rights Reserved